SCHEMBL2011563

SCHEMBL2011563

COCCOCCOCCOC(=O)C(C#N)=Cc1ccc(N(C)C)cc1

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
APP P05067 4/20 0.56
ALDH1A1 P00352 5/20 0.54
MEN1 O00255 4/20 0.54
KMT2A Q03164 4/20 0.54
PSMD14 O00487 1/20 0.54
DNM1 Q05193 3/20 0.52
PPARG P37231 1/20 0.52
RXFP1 Q9HBX9 1/20 0.52
NCOR2 Q9Y618 1/20 0.52
MAPT P10636 3/20 0.51
IDE P14735 2/20 0.50
RAB9A P51151 1/20 0.47
USP2 O75604 1/20 0.47
RECQL P46063 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
KDM4E B2RXH2 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2011561 1.00 APP (0.56) APPALDH1A1MEN1KMT2APSMD14
SCHEMBL26382501 1.00 APP (0.56) APPALDH1A1MEN1KMT2APSMD14
SCHEMBL2011560 1.00 APP (0.56) APPALDH1A1MEN1KMT2APSMD14
SCHEMBL12633780 0.97 APP (0.53) APPALDH1A1MEN1KMT2APSMD14
SCHEMBL14701202 0.91 MEN1 (0.62) APPALDH1A1MEN1KMT2APSMD14
SCHEMBL14129149 0.91 MEN1 (0.57) APPALDH1A1MEN1KMT2APSMD14
SCHEMBL12633779 0.88 ALDH1A1 (0.59) APPALDH1A1MEN1KMT2ADNM1
SCHEMBL2011668 0.88 ALDH1A1 (0.59) APPALDH1A1MEN1KMT2ADNM1
SCHEMBL2011667 0.88 ALDH1A1 (0.59) APPALDH1A1MEN1KMT2ADNM1
SCHEMBL14129172 0.87 MEN1 (0.54) APPALDH1A1MEN1KMT2APSMD14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170315137-A1 AMYLOID BINDING AGENTS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2017-11-02 US disclosed
US-9551722-B2 Amyloid binding agents THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2017-01-24 US disclosed
US-20150177262-A1 AMYLOID BINDING AGENTS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2015-06-25 US disclosed
EP-2509940-B1 AMYLOID BINDING AGENTS UNIV CALIFORNIA (US) 2015-06-10 EP disclosed
US-8940918-B2 Amyloid binding agents THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2015-01-27 US disclosed
US-20120302603-A1 AMYLOID BINDING AGENTS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-11-29 US disclosed
EP-2509940-A2 AMYLOID BINDING AGENTS The Regents of the University of California (US) 2012-10-17 EP disclosed
WO-2011072257-A2 AMYLOID BINDING AGENTS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2011-06-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120302603-A1 AMYLOID BINDING AGENTS APP, APBA1, PSEN1 APP 1/4885ALDH1A1 3897/4885MEN1 3763/4885
US-20170315137-A1 AMYLOID BINDING AGENTS APBA1, APP, PSEN1 APP 2/4885ALDH1A1 4267/4885MEN1 3531/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.